The Sudarshan Pharma Industries IPO date has been confirmed from March 9 and ended on March 14. Read the post to learn about Sudarshan Pharma Industries IPO GMP.
The IPO of Sudarshan Pharma Industries is a book built issue worth Rs 50.10 crores. This issue includes 68.62 lakh shares of all of which being of fresh shares. The bidding for IPO of the Sudarshan Pharma Industries was held on March 9, 2023, and ended on March 14, 2023. The final order was placed on March 17, 2023, Friday for this IPO. Next, on March 22, 2023, the shares got listed into the BSE SME segment.
Start your investing journey today. How do you open your own demat account for free?
Key Details Of Sudarshan Pharma Industries IPO:
Bidding Dates
March 9 – 14 ,2023
Price Range
₹71 to ₹73 per share
Face Value
₹10 per share
GMP
₹5
Sudarshan Pharma Industries IPO GMP
The Sudarshan Pharma Industries IPO IPO GMP Today is ₹[ 5 ].
Sudarshan Pharma Industries IPO Overview
The specialty chemicals sector of Sudarshan Pharma is engaged in the manufacture of chemicals and materials that are used by the pharmaceutical, agrochemical, coating, paint, adhesive, and others companies. Hospitals, governments, NGOs, and healthcare facilities could make contact with SPIL via manufacture of generic drug forms and medications under the inducement of contracts, both domestic and external, as well as through out- sourcing, and other similar approaches.
Sudarshan Pharma Industries has issued a price range for each share which is ₹71 to ₹73 for the initial public offering (IPO). The Sudarshan Pharma Industries IPO IPO GMP Today is ₹[ 5 ]. Every retail investor has to apply for a minimum lot size of 1600 shares and thus a minimum investment of ₹116,800. At the same time, very Rich and Well-off individuals, or HNIs, need to invest in 2 lots, equivalent to 3,200 shares, with a total amount of ₹233,600.
Sudarshan Pharma Industries IPO Date & Price Band Details
| IPO Date | March 9, 2023 to March 14, 2023 |
| Listing Date | March 22, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹71 to ₹73 per share |
| Lot Size | 1600 Shares |
| Total Issue Size | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Fresh Issue | 6,862,400 shares (aggregating up to ₹50.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Market Maker portion | 344,000 shares |
Sudarshan Pharma Industries IPO Market Lot
The minimum requirement for investors to bid is 1600 shares, and they can bid in multiples of this amount. The table below illustrates the minimum and maximum investment that retail investors and HNI can make in terms of shares and the corresponding amount.
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 1600 | ₹116,800 |
| Retail (Max) | 1 | 1600 | ₹116,800 |
| HNI (Min) | 2 | 3,200 | ₹233,600 |
Sudarshan Pharma Industries IPO Allotment and Listing Dates
| IPO Open Date | Thursday, March 9, 2023 |
| IPO Close Date | Tuesday, March 14, 2023 |
| Basis of Allotment | Friday, March 17, 2023 |
| Initiation of Refunds | Monday, March 20, 2023 |
| Credit of Shares to Demat | Tuesday, March 21, 2023 |
| Listing Date | Wednesday, March 22, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on March 14, 2023 |
Sudarshan Pharma Industries Company Financials
| Parameters | Period Ending on September 30, 2022 (₹ Lakhs) | Year ending on 31st March, 2022 (₹ Lakhs) | Year ending on 31st March, 2021 (₹ Lakhs) |
| Revenue from operation | 19,589.87 | 35,709.46 | 19,335.03 |
| Profit After Tax | 360.70 | 530.37 | 267.12 |
| EBITDA | NA | 1,143.57 | 754.24 |
| EBITDA Margin | NA | NA | NA |
| EPS (Basic) | NA | 3.43 | 1.75 |
| Period Ended | Year ending on As on 31st March, 2022 | Year ending on As on 31st March, 2021 | Year ending on As on 31st March, 2020 |
| Current Asset | 12,958.00 | 8,764.35 | 4,688.21 |
| Current Liabilities | 10,104.01 | 7,122.17 | 3,433.90 |
Company Profile
Started in 2008, SPIL is a Mumbai based company which is involved in supplying of generics to its international customers. Apart from this, SPI can also be connected with the import and export activities, as well as the provision of biological chemical intermediates. To fulfil specific requests of its customers, SPIL receives its components from local as well as international vendors. And it’s safe to say that the manufacturer’s supplies of ‘plastic’ are used for several industries such as glue, food, paint, and pharmaceuticals. Another notable contribution of these companies is the contracts of development, outsourcing, supply, and contract manufacturing for travel agent companies, pharmaceuticals, and other industrial sectors.
pharma formulations to hospitals, NGOs, government organizations, and healthcare institutes. With a portfolio of 50 pharmaceutical formulations, SPIL provides them as tablets, ointments, capsules, and injectables under their own brand name. In order to guarantee efficient marketing of their pharmaceutical formulations and goods, SPIL has set up a distribution network and sales force spanning five states. This enables them to cater to both the Indian and international markets. Additionally, the company offers formulation development and quality control services, providing customized solutions to their clients.
Registrar Info
| Name | Kfin Technologies Limited |
| Phone number | 04067162222, 04079611000 |
| Email ID | [email protected] |
| Website | https://kosmic.kfintech.com/ipostatus/ |
Contact Details
| Name | Sudarshan Pharma Industries |
| Phone number | 022- 42221111 |
| Email ID | [email protected] |
| Website | https://www.sudarshanpharma.com/ |
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Sudarshan Pharma Industries IPO FAQs
When Sudarshan Pharma Industries IPO will open?
The Sudarshan Pharma Industries IPO opens on March 9, 2023 and closes on March 14, 2023.
What is the lot size of Sudarshan Pharma Industries IPO?
Sudarshan Pharma Industries IPO lot size is 1600 Shares, and the minimum amount required is ₹116,800.
When is Sudarshan Pharma Industries IPO allotment?
The finalization of Basis of Allotment for Sudarshan Pharma Industries IPO will be done on Friday, March 17, 2023, and the allotted shares will be credited to your demat account by Tuesday, March 21, 2023.
When is Sudarshan Pharma Industries IPO listing date?
Leave a Reply